Geode Capital Management, LLC Avidity Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,807,455 shares of RNA stock, worth $87.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,807,455

Previous 2,585,303 8.59%

Holding current value

$87.4 Million

Previous $119 Million 31.25%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$29.08 - $52.5 $6.46 Million - $11.7 Million	222,152 Added 8.59%	2,807,455 $81.6 Million
Q3 2024 Nov 12, 2024	BUY	$37.21 - $48.14 $12.2 Million - $15.8 Million	328,606 Added 14.56%	2,585,303 $119 Million
Q2 2024 Aug 09, 2024	BUY	$22.73 - $40.85 $14.9 Million - $26.8 Million	657,023 Added 41.07%	2,256,697 $92.2 Million
Q1 2024 May 13, 2024	BUY	$9.16 - $25.52 $480,533 - $1.34 Million	52,460 Added 3.39%	1,599,674 $40.8 Million
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $543,789 - $1.05 Million	111,661 Added 7.78%	1,547,214 $14 Million
Q3 2023 Nov 13, 2023	SELL	$6.3 - $11.35 $18,881 - $34,015	-2,997 Reduced 0.21%	1,435,553 $9.16 Million
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $1.45 Million - $2.37 Million	136,517 Added 10.48%	1,438,550 $16 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $2.76 Million - $4.61 Million	179,655 Added 16.01%	1,302,033 $20 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $1.84 Million - $4.14 Million	182,754 Added 19.45%	1,122,378 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $1.41 Million - $2.13 Million	90,923 Added 10.71%	939,624 $15.3 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $1.25 Million - $2.29 Million	111,605 Added 15.14%	848,701 $12.3 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $324,541 - $543,491	22,855 Added 3.2%	737,096 $13.6 Million
Q4 2021 Feb 11, 2022	SELL	$20.4 - $28.66 $510,509 - $717,216	-25,025 Reduced 3.39%	714,241 $17 Million
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $5.93 Million - $8.23 Million	326,589 Added 79.14%	739,266 $18.2 Million
Q2 2021 Aug 13, 2021	BUY	$19.62 - $29.26 $137,398 - $204,907	7,003 Added 1.73%	412,677 $10.2 Million
Q1 2021 May 12, 2021	BUY	$20.28 - $28.15 $2.84 Million - $3.94 Million	140,086 Added 52.75%	405,674 $8.85 Million
Q4 2020 Feb 12, 2021	SELL	$24.73 - $35.12 $124,861 - $177,320	-5,049 Reduced 1.87%	265,588 $6.78 Million
Q3 2020 Nov 13, 2020	BUY	$23.35 - $35.94 $5.92 Million - $9.12 Million	253,706 Added 1498.47%	270,637 $7.62 Million
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $450,703 - $533,326	16,931 New	16,931 $478,000

Others Institutions Holding RNA

# of Institutions

257

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.62B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Avidity Biosciences, Inc. Transaction History